Post job

Axsome Therapeutics overview

Industry
Physicians and Health Practitioners
Revenue
Headquarters
Employees
29
Founded in
Website
Organization type
Public
Social media
Axsome Therapeutics is a biopharmaceutical company developing novel therapies for the treatment of pain and other neurological diseases. By focusing on this therapeutic area, Axsome is addressing growing markets where current treatment options are limited or inadequate. Axsome has a balanced portfolio of clinical development stage as well as research stage products. Axsome Therapeutics aims to become a fully integrated biopharmaceutical company that develops and commercializes differentiated products which increase the armamentarium of caregivers and improve the lives of patients. While the focus of the company is on developing its internally derived product candidates, Axsome also evaluates potential in-licensing opportunities to supplement its current portfolio.
Axsome Therapeutics is a small health care company based in New York, NY with only 29 employees and an annual revenue of $385.7M.

Axsome Therapeutics's mission statement

Transforming the CNS treatment approach by developing therapeutic options that improve patients lives in a meaningful way.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Axsome Therapeutics employee reviews

Be the first to review!

Do you work at Axsome Therapeutics?

Help job seekers learn about working at Axsome Therapeutics

Job openings at Axsome Therapeutics
351 positions

On this page

Be the first to review Axsome Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Axsome Therapeutics?

The team at Axsome Therapeutics

  • The founders of Axsome Therapeutics are Herriott Tabuteau and Roger A. Jeffs.
  • The key people at Axsome Therapeutics are Herriott Tabuteau and Roger A. Jeffs.
Key people
Herriott Tabuteau
Roger A. Jeffs

Rate the fairness of Axsome Therapeutics' compensation policies.

Zippia waving zebra

Do you work at Axsome Therapeutics?

Does Axsome Therapeutics actively promote diversity and inclusion?

Axsome Therapeutics financial performance

6.1
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Axsome Therapeutics currently has 50.0M in revenue. Axsome Therapeutics's most recent quarter produced 46.7m (q2'2023).

Axsome Therapeutics annual revenue

$386M
$309M
$231M
$154M
$77M
$0
2022
2023
2024

Are you an executive, HR leader, or brand manager at Axsome Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Axsome Therapeutics FAQs

Search for jobs

Most common locations at Axsome Therapeutics

Zippia gives an in-depth look into the details of Axsome Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Axsome Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Axsome Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Axsome Therapeutics. The data presented on this page does not represent the view of Axsome Therapeutics and its employees or that of Zippia.

Axsome Therapeutics may also be known as or be related to AXSOME THERAPEUTICS INC., Axsome Therapeutics, Axsome Therapeutics Inc, Axsome Therapeutics Inc. and Axsome Therapeutics, Inc.